Year All20252024202320222021202020192018201720162015201420122011 Jun 3, 2015 Ardelyx to Raise $77.8 Million in a Private Placement and Announces New Product Candidate for the Treatment of Hyperkalemia to Begin Clinical Development in Mid-2015 May 19, 2015 Ardelyx Presents Positive Results from Its Phase 2b Clinical Trial Evaluating Tenapanor in IBS-C Patients at Digestive Disease Week 2015 May 12, 2015 Ardelyx Reports First Quarter 2015 Financial Results May 5, 2015 Ardelyx Reports Results from Phase 2a Clinical Trial Evaluating Tenapanor in Chronic Kidney Disease Patients with Type 2 Diabetes Mellitus and Albuminuria Apr 20, 2015 Ardelyx Appoints Dr. Annalisa Jenkins to Its Board of Directors Mar 13, 2015 Ardelyx to Present at the 22nd Annual Future Leaders in the Biotech Industry Conference Feb 25, 2015 Ardelyx Reports Fourth Quarter and Full Year 2014 Financial Results Feb 18, 2015 Ardelyx to Report Fourth Quarter and Full Year 2014 Financial Results on February 25th, 2015 Feb 9, 2015 Ardelyx to Present at the 2015 Leerink Global Healthcare Conference Feb 2, 2015 Ardelyx Reports Results from Phase 2b Clinical Trial Evaluating Tenapanor in Treating Hyperphosphatemia in Chronic Kidney Disease Patients on Hemodialysis